Company Profile
iSpecimen Stock Price, News & Analysis
- Ticker:
- ISPC
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, iSpecimen is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
2.54 USD (+0.79%)
Close
Last updated: June 23, 2026 at 00:00
3.65M USD
Market cap
Why the stock is moving
ISPC is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
iSpecimen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, iSpecimen is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
iSpecimen follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, iSpecimen sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
iSpecimen to Report Third Quarter 2022 Results on November 8, 2022
Source: iSpecimen
- 03
- 04
iSpecimen Reports Third Quarter 2022 Financial and Operating Results
Source: iSpecimen
- 05
iSpecimen Appoints Joseph J. Basile to Board of Directors
Source: iSpecimen
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of iSpecimen (ISPC)?
iSpecimen (ISPC) most recently closed at 2.54 USD, a +0.79% move versus the previous session.
What is the market cap of iSpecimen (ISPC)?
iSpecimen currently has a market capitalization of 3.65M USD on BioPharmSignal.
What does iSpecimen do?
iSpecimen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ISPC stock listed?
iSpecimen (ISPC) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, iSpecimen is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is iSpecimen targeting with Investors?
iSpecimen is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.